These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19385951)

  • 1. 'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.
    Worm M
    Allergy; 2009 Jul; 64(7):1104-5. PubMed ID: 19385951
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
    Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
    J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):244. PubMed ID: 17124783
    [No Abstract]   [Full Text] [Related]  

  • 6. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.
    Didier A; Melac M; Montagut A; Lhéritier-Barrand M; Tabar A; Worm M
    Allergy; 2009 Jan; 64(1):166-71. PubMed ID: 19076546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
    Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
    Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet.
    de Groot H; Bijl A
    Allergy; 2009 Jun; 64(6):963-4. PubMed ID: 19222420
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial.
    Röder E; Berger MY; de Groot H; Gerth van Wijk R
    Clin Exp Allergy; 2008 Oct; 38(10):1659-67. PubMed ID: 18631346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
    Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
    J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX) in a randomized, open-label, controlled study: an a priori subgroup analysis.
    Jansen A; Andersen KF; Brüning H
    Clin Ther; 2009 Feb; 31(2):321-7. PubMed ID: 19302904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific immunotherapy in allergy treatment. Evidence for subcutaneous and sublingual administration].
    Kreutzkamp B
    Med Monatsschr Pharm; 2008 Dec; 31(12):473-7. PubMed ID: 19133596
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and effectiveness of sublingual immunotherapy for grass pollen allergy.
    Marcucci F
    Eur J Intern Med; 2016 May; 30():e21. PubMed ID: 27012472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Grazax--treatment for grass pollen hay fever].
    Svendsen UG
    Ugeskr Laeger; 2008 Jan; 170(3):135-7. PubMed ID: 18208728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and effectiveness of sublingual immunotherapy for grass pollen allergy: Reply to the letter of Marcucci F.
    Salvatore C
    Eur J Intern Med; 2016 May; 30():e22. PubMed ID: 26778720
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral reactions to sublingual immunotherapy: a bioptic study.
    Marcucci F; Sensi L; Incorvaia C; Di Cara G; Moingeon P; Frati F
    Allergy; 2007 Dec; 62(12):1475-7. PubMed ID: 17983387
    [No Abstract]   [Full Text] [Related]  

  • 17. Sublingual immunotherapy for inhalant allergy: cautious optimism.
    Krouse JH
    Otolaryngol Head Neck Surg; 2009 May; 140(5):622-4. PubMed ID: 19393399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial with purified natural major allergens from grass pollen.
    Fernández-Rivas M; Brewczynski PZ; Kroon AM; van Ree R
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):131-6; discussion 136-8. PubMed ID: 11487867
    [No Abstract]   [Full Text] [Related]  

  • 19. Undertreatment of allergy: exploring the utility of sublingual immunotherapy.
    Emanuel IA; Parker MJ; Traub O
    Otolaryngol Head Neck Surg; 2009 May; 140(5):615-21. PubMed ID: 19393398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
    Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
    Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.